Kaiser Permanente Northwest Oncology Hematology
Portland, Oregon, United States
Medical center in Portland, Oregon
3800 N Interstate Ave, Portland, OR 97227
About Kaiser Permanente Northwest Oncology Hematology
"Health care leader whose mission is to keep you healthy. Under-one-roof convenience, 24-hour advice nurse, and online access to manage your health anytime."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
4
NSABP Foundation Inc
1
OncoMed Pharmaceuticals, Inc.
1
Telik
1
Clinical Trials at Kaiser Permanente Northwest Oncology Hematology
During the past decade, Kaiser Permanente Northwest Oncology Hematology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on
average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
2003-06-01
2006-12-01
Completed
440
Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma
2008-08-21
2016-07-14
Completed
1,623
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy
2009-01-27
2020-10-27
Completed
317
The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)
2013-04-26
2023-06-30
Active, not recruiting
216
Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission
2013-04-24
2023-12-31
Active, not recruiting
472
Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma
2015-04-20
2017-09-01
Completed
207
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
2017-12-19
2024-06-30
Active, not recruiting
1,550
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Northwest Oncology Hematology"
#1 collaborator was "Celgene Corporation" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Kaiser Permanente Northwest Oncology Hematology
According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Northwest Oncology Hematology" are
"B-cell Chronic Lymphocytic Leukemia" (1 trials), "Leukemia, Myeloid, Acute" (1 trials), "Multiple Myeloma" (1 trials), "Myelodysplastic Syndrome" (1 trials) and "Ovarian Neoplasms" (1 trials). Many other conditions were trialed in "Kaiser Permanente Northwest Oncology Hematology" in a lesser frequency.
Clinical Trials Intervention Types at Kaiser Permanente Northwest Oncology Hematology
Most popular intervention types in "Kaiser Permanente Northwest Oncology Hematology" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Oral Azacitidine" (2 trials), "Abraxane®" (1 trials), "Atezolizumab" (1 trials) and "Best Supportiv Care (BSC)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kaiser Permanente Northwest Oncology Hematology
The vast majority of trials in "Kaiser Permanente Northwest Oncology Hematology" are
6 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Kaiser Permanente Northwest Oncology Hematology
Currently, there are NaN active trials in "Kaiser Permanente Northwest Oncology Hematology".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Kaiser Permanente Northwest Oncology Hematology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kaiser Permanente Northwest Oncology Hematology, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".